These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Alterations of the pulmonary static mechanical properties and of the tensioactive substance of the alveolar lining caused by ethyl alcohol]. Bracco M; Curti PC; Camerota G Ann Ist Carlo Forlanini; 1969; 29(3):273-80. PubMed ID: 4110346 [No Abstract] [Full Text] [Related]
4. [Therapeutic study with metabolit 8 of bromhexine in deficiency of alveoli surface-active substance]. Curti PC Arzneimittelforschung; 1974 Jun; 24(6):847-9. PubMed ID: 4408139 [No Abstract] [Full Text] [Related]
5. [Activity of anesthetics on pulmonary static mechanical properties and on the tensioactive substance of the alveolar lining]. Curti PC; Bracco M Ann Ist Carlo Forlanini; 1969; 29(3):253-65. PubMed ID: 4110345 [No Abstract] [Full Text] [Related]
6. [Alterations of pulmonary static mechanical properties and of the tensioactive substance of the alveolar lining caused by cigarette smoke]. Bracco M; Curti PC; Camerota G Ann Ist Carlo Forlanini; 1969; 29(3):267-72. PubMed ID: 5409301 [No Abstract] [Full Text] [Related]
7. [Importance of surface active substances in the lung]. Kadlec K; Kandus J Vnitr Lek; 1972 Jun; 18(6):521-31. PubMed ID: 5068058 [No Abstract] [Full Text] [Related]
8. [Variations of the elasticity and distensibility of rat lung caused by administration of some drugs and considerations on the technic of the pulmonary tension-volume curve and the modifications obtained in different experimental pathological conditions]. Cornia G; Mannino F Ann Ist Carlo Forlanini; 1969; 29(3):239-51. PubMed ID: 5409300 [No Abstract] [Full Text] [Related]
9. [Ultrastructural modifications of lung induced by oxygen. Physiopathologic consequences]. Pariente R; Jeannin L; Pfister D; Brouet G Poumon Coeur; 1970; 26(8):877-91. PubMed ID: 5516126 [No Abstract] [Full Text] [Related]
10. [The presence of the "surfactant-system" in the lung as a condition for the repression of upper respiratory tract diseases. 3. Clinical material]. Wildeboer-Venema FN Ned Tijdschr Geneeskd; 1971 Sep; 115(37):1533-8. PubMed ID: 5109628 [No Abstract] [Full Text] [Related]
11. [Behavior of surface-active film in the pulmonary alveoli after volatile oil inhalation]. Stolz C Med Welt; 1972 Sep; 26(36):1209-11. PubMed ID: 4678407 [No Abstract] [Full Text] [Related]
12. [Surface-active properties of lung extracts with different functional states of the adrenal glands]. Kriuchkova VI Fiziol Zh SSSR Im I M Sechenova; 1972 Apr; 58(4):596-8. PubMed ID: 5067546 [No Abstract] [Full Text] [Related]
14. [Pulmonary surfactan. Current physiological and physiopathological concepts]. Pariente R Presse Med (1893); 1969 Nov; 77(50):1871-2. PubMed ID: 5197179 [No Abstract] [Full Text] [Related]
15. Physiology and pathology of pulmonary surfactants. Scarpelli EM Triangle; 1971; 10(2):47-56. PubMed ID: 5170861 [No Abstract] [Full Text] [Related]
16. [Importance of the "surfactant system" in the pathogenesis of hyaline membrane in the newborn]. Cosmi EV; Condorelli S; Scarpelli EM Acta Anaesthesiol; 1970; 31():Suppl:69-94. PubMed ID: 5538013 [No Abstract] [Full Text] [Related]
18. Effect of detergent solutions upon distal lung phospholipids. Tapu V; Eskenasy A Morphol Embryol (Bucur); 1983; 29(3):197-201. PubMed ID: 6230528 [TBL] [Abstract][Full Text] [Related]
19. Expanded use of surfactant therapy in newborns. Lacaze-Masmonteil T Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937 [TBL] [Abstract][Full Text] [Related]
20. Modification of pulmonary surfactant in the rat by vitamin A, pilocarpine and paraquat. Ivemark B; Robertson B J Pathol; 1970 Aug; 101(4):P13. PubMed ID: 5537331 [No Abstract] [Full Text] [Related] [Next] [New Search]